Lianya Pharma and Southern Dairy IPOs open for subscription on September 28
Two new stocks, Lianya Pharmaceutical and Southern Dairy, will open for subscription on September 28 on the Shenzhen and Beijing stock exchanges respectively. Lianya Pharma, a complex drug formulation developer with leading U.S. market shares, is offering 134 million shares at 7 yuan each. Southern Dairy, a Guizhou-based dairy producer, is offering 35.19 million shares at 14.21 yuan each. Lianya's large issuance ranks 11th among Shanghai and Shenzhen IPOs since 2026.
Reference imageEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary awaiting refresh
Summary awaiting refresh
Cross-source coverage
Reporting timeline
Two New Stocks to List Next Week; Lianhe Pharma IPO Offers High Lottery Chance
According to a report from China Fund News, A-share IPO investors should note that two new stocks will be available for subscription next week, both on September 28. The first is Southern Dairy (920196), a leading dairy company in Guizhou, listing on the Beijing Stock Exchange with an issue price of 14.21 yuan per share and a P/E ratio of 11.99. The second is Lianhe Pharma (301569), a high-end pharmaceutical formulation exporter, listing on the Shenzhen Stock Exchange's ChiNext board with an issue price of 7 yuan per share and a P/E ratio of 27.99. The report highlights that Lianhe Pharma's total issued shares rank 11th among all Shanghai and Shenzhen stocks since 2026, implying a higher probability of winning the lottery for investors. Southern Dairy's revenue is heavily concentrated in Guizhou (over 90%), while Lianhe Pharma has leading market share in the US for several of its products. Financial forecasts show Southern Dairy expects a slight decline in net profit for the first three quarters of 2026, while Lianhe Pharma expects significant net profit growth of 35-50% for the same period.
Read sourceTwo New Stocks Available for Subscription Next Week: Southern Dairy and Lianya Pharma
According to a report by China Fund News, two new stocks will be available for subscription next week on September 28: Southern Dairy on the Beijing Stock Exchange and Lianya Pharmaceutical on the Shenzhen Stock Exchange's ChiNext board. Southern Dairy, a Guizhou-based dairy leader, is offering 35.19 million shares at 14.21 yuan per share, with a P/E ratio of 11.99. Its revenue is concentrated in Guizhou, though it is expanding to neighboring regions. Lianya Pharmaceutical, a benchmark for high-end generic drug exports, is offering 134 million shares at 7 yuan per share, with a P/E ratio of 27.99. The company specializes in complex drug formulations and holds leading market shares in the US for several products. The report notes that Lianya's total share issuance ranks 11th among all Shanghai and Shenzhen new stocks since 2026, suggesting a higher probability of allocation for subscribers.
Read sourceTwo New Stocks, Lianhe Yiyao and Southern Dairy, Open for Subscription on Monday
According to a report from China News Service via Sina Finance, two new stocks will be available for subscription on September 28, 2025. Lianhe Yiyao (Union Pharma), listed on the ChiNext board, is a complex drug formulation developer with an IPO price of 7.00 yuan per share, corresponding to a diluted P/E ratio of 23.79. The company has high overseas revenue exposure, with 63.15% of sales from abroad in 2025, primarily from the U.S., and relies heavily on its largest customer, Ingenus Pharmaceuticals, for over 55% of revenue. Southern Dairy, listed on the Beijing Stock Exchange, is a Guizhou-based dairy producer with an IPO price of 14.21 yuan per share and a post-issuance P/E of 11.99. It generates over 90% of its revenue within Guizhou province and faces challenges expanding nationally against giants like Yili and Mengniu. The company's R&D spending over the past three years averaged 0.82% of revenue. Southern Dairy forecasts a potential net profit decline of up to 9.34% year-on-year for the first nine months of 2026.
Read sourceShow 3 older updatesHide older updates
Two New Stocks Available for Subscription Next Week, Including High-Chance IPO
According to a report from East Money News, two new stocks will be available for subscription on September 28: Southern Dairy (code 920196) on the Beijing Stock Exchange and Lianya Pharmaceutical (code 301569) on the Shenzhen Stock Exchange. Lianya Pharmaceutical is highlighted as having a high probability of allocation due to its large issuance of 134 million shares, ranking 11th among Shanghai and Shenzhen IPOs since 2026. Southern Dairy, priced at 14.21 yuan per share with a P/E ratio of 11.99, is a regional dairy company focused on Guizhou province, with over 90% of revenue from the area. It reported stable revenue of around 18 billion yuan from 2023 to 2025 but expects a slight decline in net profit for the first three quarters of 2026. Lianya Pharmaceutical, priced at 7 yuan per share with a P/E ratio of 27.99, is a leader in complex drug formulations, with several products holding top U.S. market shares. It reported growing revenue and expects a significant net profit increase of 35-50% for the first three quarters of 2026.
Read sourceTwo New Stocks Available for Subscription Next Week: Lianya Pharma and Southern Dairy
According to a report from People's Financial News on September 26, citing Securities Times·DataBao statistics, two new stocks are tentatively scheduled for subscription next week. On Monday, September 28, investors can subscribe to Lianya Pharmaceutical (stock code 301569) and Southern Dairy (stock code 920196). The total estimated fundraising amount for the new stocks to be issued next week is 14.36 billion yuan. Lianya Pharmaceutical plans to publicly issue 134 million A-shares, with an online tranche of 18.7235 million shares, an issue price of 7.00 yuan, and a maximum subscription of 18,500 shares per account. The company reported net profits of 116 million yuan, 260 million yuan, and 228 million yuan for 2023, 2024, and 2025 respectively, with year-on-year changes of 2.47%, 124.68%, and -12.43%. Southern Dairy plans to publicly issue 35.1852 million A-shares, with an online tranche of 24.6296 million shares, and an issue price of 14.21 yuan.
Read sourceTwo New Stocks Available for Subscription Next Week: Lianya Pharma and Southern Dairy
According to a report from Securities Times citing DataBao statistics, two new stocks are scheduled for subscription next week on the A-share market. On Monday, September 28, investors can subscribe to Lianya Pharma (ticker: 301569) and Southern Dairy (ticker: 920196). Lianya Pharma plans to publicly issue 134 million A-shares, with 18.7235 million shares available for online subscription. The issue price is 7.00 yuan per share, with a maximum subscription of 18,500 shares per account, requiring a Shenzhen market holding of 185,000 yuan for the maximum subscription. The company reported net profits of 116 million yuan, 260 million yuan, and 228 million yuan for 2023, 2024, and 2025 respectively, representing year-on-year changes of 2.47%, 124.68%, and -12.43%. Southern Dairy plans to publicly issue 35.1852 million A-shares, with 24.6296 million shares available for online subscription, at an issue price of 14.21 yuan per share. The information was sourced from Securities Times Network.